Cellular Analytics is using a new technology for liquid biopsy - CytoFind™ - that reports on the phenotypic properties of tumors and metastatic disease.

 

By providing information on the molecular-level features of a tumor in real-time, patients can be matched with the most effective therapy for improved outcomes.